Skip Navigation
Skip to contents

JPMPH : Journal of Preventive Medicine and Public Health

OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
49 "Neoplasms"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Original Articles
Health-related Quality of Life in Elderly Asian American and Non-Hispanic White Cancer Survivors
Suzanne Vang
J Prev Med Public Health. 2023;56(5):440-448.   Published online September 13, 2023
DOI: https://doi.org/10.3961/jpmph.22.464
  • 736 View
  • 59 Download
AbstractAbstract AbstractSummary PDF
Objectives
The purpose of this study was to assess predictors of health-related quality of life (HRQoL) in elderly Asian American and non-Hispanic White cancer survivors.
Methods
We conducted cross-sectional secondary data analyses using the combined datasets from the Surveillance, Epidemiology, and End Results program and the Medicare Health Outcomes Survey.
Results
Elderly Asian American cancer survivors reported a lower mental HRQoL but a comparable physical HRQoL relative to elderly non-Hispanic White cancer survivors. Stress factors, such as comorbidities, difficulties with activities of daily living, and a history of depressive symptoms, along with coping resources like self-rated health and the ability to take the survey in English, were significantly associated with mental and physical HRQoL. Among elderly Asian American cancer survivors, a significantly lower mental HRQoL was observed among those taking the survey in the Chinese language.
Conclusions
The findings suggest that race exerts a differential impact on HRQoL. Interventions should be designed to address the distinct cultural, linguistic, and systemic needs of elderly Asian American cancer survivors. Such an approach could assist in reducing cancer-related health disparities.
Summary
Key Message
Secondary data analyses of the Surveillance, Epidemiology, and End Results program and the Medicare Health Outcomes Survey combined datasets reveal that elderly Asian American cancer survivors had poorer mental health-related quality of life (HRQoL) compared to their non-Hispanic White counterparts. Elderly Asian American cancer survivors who did not complete the survey in English had significantly worse mental HRQoL than their Asian American counterparts who did. These findings point to the need for increased research to identify and address the distinct cultural, linguistic, and system-related needs of elderly Asian American cancer survivors in order to optimize HRQoL in this population.
Operational Definitions of Colorectal Cancer in the Korean National Health Insurance Database
Hyeree Park, Yu Rim Kim, Yerin Pyun, Hyundeok Joo, Aesun Shin
J Prev Med Public Health. 2023;56(4):312-318.   Published online May 31, 2023
DOI: https://doi.org/10.3961/jpmph.23.033
  • 1,791 View
  • 109 Download
  • 2 Crossref
AbstractAbstract AbstractSummary PDFSupplementary Material
Objectives
We reviewed the operational definitions of colorectal cancer (CRC) from studies using the Korean National Health Insurance Service (NHIS) and compared CRC incidence derived from the commonly used operational definitions in the literature with the statistics reported by the Korea Central Cancer Registry (KCCR).
Methods
We searched the MEDLINE and KoreaMed databases to identify studies containing operational definitions of CRC, published until January 15, 2021. All pertinent data concerning the study period, the utilized database, and the outcome variable were extracted. Within the NHIS-National Sample Cohort, age-standardized incidence rates (ASRs) of CRC were calculated for each operational definition found in the literature between 2005 and 2019. These rates were then compared with ASRs from the KCCR.
Results
From the 62 eligible studies, 9 operational definitions for CRC were identified. The most commonly used operational definition was “C18-C20” (n=20), followed by “C18-C20 with claim code for treatment” (n=3) and “C18-C20 with V193 (code for registered cancer patients’ payment deduction)” (n=3). The ASRs reported using these operational definitions were lower than the ASRs from KCCR, except for “C18-C20 used as the main diagnosis.” The smallest difference in ASRs was observed for “C18-C20,” followed by “C18- C20 with V193,” and “C18-C20 with claim code for hospitalization or code for treatment.”
Conclusions
In defining CRC patients utilizing the NHIS database, the ASR derived through the operational definition of “C18-C20 as the main diagnosis” was comparable to the ASR from the KCCR. Depending on the study hypothesis, operational definitions using treatment codes may be utilized.
Summary
Korean summary
- 국민건강보험공단 자료 기반 연구에서 사용된 대장암의 조작적 정의를 검토하고 각 조작적 정의에 따른 대장암의 연령표준화발생률을 중앙암등록본부에서 보고한 수치와 비교하였다. - 62개의 출판된 문헌을 검토하여 9개의 조작적 정의를 확인하였고 이 중 "C18-C20"이 가장 일반적으로 사용되었다. - "C18-C20"을 주진단으로 정의한 경우의 연령표준화발생률은 중앙암등록본부에서 보고한 연령표준화발생률과 가장 유사하였다.

Citations

Citations to this article as recorded by  
  • National Trends in Rotavirus Enteritis among Infants in South Korea, 2010–2021: A Nationwide Cohort
    Hyun Jee Lee, Yujin Choi, Jaeyu Park, Yong-Sung Choi, Dong Keon Yon, Do Hyun Kim
    Children.2023; 10(9): 1436.     CrossRef
  • Real-world data analysis on effectiveness of integrative therapies: A practical guide to study design and data analysis using healthcare databases
    Ye-Seul Lee, Yoon Jae Lee, In-Hyuk Ha
    Integrative Medicine Research.2023; 12(4): 101000.     CrossRef
Projection of Cancer Incidence and Mortality From 2020 to 2035 in the Korean Population Aged 20 Years and Older
Youjin Hong, Sangjun Lee, Sungji Moon, Soseul Sung, Woojin Lim, Kyungsik Kim, Seokyung An, Jeoungbin Choi, Kwang-Pil Ko, Inah Kim, Jung Eun Lee, Sue K. Park
J Prev Med Public Health. 2022;55(6):529-538.   Published online October 17, 2022
DOI: https://doi.org/10.3961/jpmph.22.128
  • 2,912 View
  • 174 Download
  • 1 Crossref
AbstractAbstract AbstractSummary PDFSupplementary Material
Objectives
This study aimed to identify the current patterns of cancer incidence and estimate the projected cancer incidence and mortality between 2020 and 2035 in Korea.
Methods
Data on cancer incidence cases were extracted from the Korean Statistical Information Service from 2000 to 2017, and data on cancer-related deaths were extracted from the National Cancer Center from 2000 to 2018. Cancer cases and deaths were classified according to the International Classification of Diseases, 10th edition. For the current patterns of cancer incidence, age-standardized incidence rates (ASIRs) and age-standardized mortality rates were investigated using the 2000 mid-year estimated population aged over 20 years and older. A joinpoint regression model was used to determine the 2020 to 2035 trends in cancer.
Results
Overall, cancer cases were predicted to increase from 265 299 in 2020 to 474 085 in 2035 (growth rate: 1.8%). The greatest increase in the ASIR was projected for prostate cancer among male (7.84 vs. 189.53 per 100 000 people) and breast cancer among female (34.17 vs. 238.45 per 100 000 people) from 2000 to 2035. Overall cancer deaths were projected to increase from 81 717 in 2020 to 95 845 in 2035 (average annual growth rate: 1.2%). Although most cancer mortality rates were projected to decrease, those of breast, pancreatic, and ovarian cancer among female were projected to increase until 2035.
Conclusions
These up-to-date projections of cancer incidence and mortality in the Korean population may be a significant resource for implementing cancer-related regulations or developing cancer treatments.
Summary
Korean summary
최근 고령화 시대로 접어들고 암의 위험요인들에 대한 노출률이 변화함에 따라 암의 발생률 및 사망률에 대해서 관찰하는 것은 중요한 일이 되었다. 따라서, 본 연구는 한국인에서 2035년까지의 암에 대한 발생률과 사망률을 Joinpoint regression 모델을 이용하여 예측하였다. 남성에서는 전립선암, 여성에서는 유방암이 연령표준화 발생률이 가장 높았으며 대부분의 연령표준화 사망률은 감소하는 것으로 예상되지만 여성의 유방암, 췌장암, 난소암이 증가될 것으로 예상된다.

Citations

Citations to this article as recorded by  
  • Changes in metabolic syndrome and the risk of breast and endometrial cancer according to menopause in Korean women
    Thi Xuan Mai Tran, Soyeoun Kim, Boyoung Park
    Epidemiology and Health.2023; 45: e2023049.     CrossRef
The Association Between Metabolic Syndrome and Colorectal Cancer Risk by Obesity Status in Korean Women: A Nationwide Cohort Study
Seong-geun Moon, Boyoung Park
J Prev Med Public Health. 2022;55(5):475-484.   Published online September 21, 2022
DOI: https://doi.org/10.3961/jpmph.22.286
  • 2,304 View
  • 105 Download
  • 1 Web of Science
  • 1 Crossref
AbstractAbstract AbstractSummary PDFSupplementary Material
Objectives
This study aimed to determine the association between metabolic syndrome (MetS) and the incidence of colorectal cancer (CRC) in Korean women with obesity.
Methods
Cancer-free women (n=6 142 486) aged 40-79 years, who underwent National Health Insurance Service health examinations in 2009 and 2010 were included. The incidence of CRC was followed until 2018. The hazard ratio (HR) of MetS for the incidence of colon and rectal cancer was analyzed according to body mass index (BMI) categories, adjusting for confounders such as women’s reproductive factors. In addition, the heterogeneity of associations across BMI categories was assessed.
Results
Women with MetS were at increased risk of colon and rectal cancer compared to women without MetS (HR, 1.20; 95% confidence interval [CI], 1.16 to 1.23 and HR,1.15; 95% CI, 1.11 to 1.20), respectively. The HR of MetS for colon cancer across BMI categories was 1.12 (95% CI, 1.06 to 1.19), 1.14 (95% CI, 1.08 to 1.20), and 1.16 (95% CI, 1.12 to 1.21) in women with BMIs <23.0 kg/m2, 23.0-24.9 kg/m2, and ≥25.0 kg/m2, respectively. The HR of MetS for rectal cancer across corresponding BMI categories was 1.16 (95% CI, 1.06 to 1.26), 1.14 (95% CI, 1.05 to 1.23), and 1.13 (95% CI, 1.06 to 1.20). The heterogeneity of associations across BMI categories was not significant in either colon or rectal cancer (p=0.587 for colon cancer and p=0.927 for rectal cancer).
Conclusions
Women with MetS were at increased risk of colon and rectal cancer. Clinical and public health strategies should be considered for primary CRC prevention with an emphasis on improving women’s metabolic health across all BMI groups.
Summary
Korean summary
한국 여성에서 대사증후군은 대장암 발생과 직장암 발생에 유의한 위험요인으로 보인다. 이는 체질량지수를 층화하고 여성력과 관련된 요인들을 보정하더라도 유의했다. 한국 여성의 대장암 및 직장암 예방을 위해 비만도에 관계 없이 대사증후군 요소를 관리하는 것이 필요하다.

Citations

Citations to this article as recorded by  
  • Increased risk of cancer and cancer-related mortality in middle-aged Korean women with prediabetes and diabetes: a population-based study
    Thi Xuan Mai Tran, Soyeoun Kim, Huiyeon Song, Boyoung Park
    Epidemiology and Health.2023; 45: e2023080.     CrossRef
Special Article
Statin Intake and Gastric Cancer Risk: An Updated Subgroup Meta-analysis Considering Immortal Time Bias
Jong-Myon Bae
J Prev Med Public Health. 2022;55(5):424-427.   Published online August 18, 2022
DOI: https://doi.org/10.3961/jpmph.22.209
  • 2,139 View
  • 86 Download
  • 1 Web of Science
  • 1 Crossref
AbstractAbstract AbstractSummary PDF
A retrospective record-linkage study (RLS) based on medical records containing drug prescription histories involves immortal time bias (ITB). Thus, it is necessary to control for this bias in the research planning and analysis stages. Furthermore, a summary of a metaanalysis including RLSs that did not control for ITB showed that specific drugs had a preventive effect on the occurrence of the disease. Previous meta-analytic results of three systematic reviews evaluating the association between statin intake and gastric cancer risk showed that the summary hazard ratio (sHR) of the RLSs was lower than 1 and was statistically significant. We should consider the possibility of ITB in the sHR of RLSs and interpret the results carefully.
Summary
Korean summary
이차자료를 활용하여 구축한 코호트 추적연구는 immortal time bias가 개입될 개연성을 염두에 두어야 한다. 이들 연구결과들을 제외한 메타분석 결과 스타닌 복용에 따른 위암발생 위험 감소는 관련성이 없다는 결과를 도출하였다.

Citations

Citations to this article as recorded by  
  • Sodium-glucose cotransporter-2 inhibitors use and the risk of gout: a systematic review and meta-analysis
    Shih-Wei Lai, Bing-Fang Hwang, Yu-Hung Kuo, Chiu-Shong Liu, Kuan-Fu Liao
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
Original Articles
Estimation of Utility Weights for Prostate-related Health States in Korea
Seon-Ha Kim, Minsu Ock, Min-Woo Jo, Sungchan Park
J Prev Med Public Health. 2022;55(3):243-252.   Published online May 4, 2022
DOI: https://doi.org/10.3961/jpmph.21.426
  • 2,412 View
  • 85 Download
AbstractAbstract AbstractSummary PDFSupplementary Material
Objectives
Very limited previous research has investigated the utility weights of prostate-related diseases in the general population in Korea. The purpose of this study was to calculate the utility of prostate-related health states in the Korean general public using the standard gamble (SG) method.
Methods
Seven health states for hypothetical prostate cancers, 1 for benign prostate hyperplasia, and 1 for erectile dysfunction were developed based on patient education material and previous publications. In total, 460 responses from the Korean general population were used to analyze the utility of prostate-related health states. Computer-assisted personal interviews were conducted, and utility values were measured using a visual analogue scale (VAS) and SG. Mean utility values were calculated for each prostate-related health state.
Results
The mean utility values of prostate cancer derived from SG ranged from 0.281 (metastatic castration-refractory prostate cancer) to 0.779 (localized prostate cancer requiring prostatectomy). The utility value of benign prostate hyperplasia was 0.871, and that of erectile dysfunction was 0.812. The utility values obtained using the SG method in all conditions were higher than the values obtained by VAS. There were no significant demographic variables affecting utility values in multivariate analysis.
Conclusions
Our findings might be useful for economic evaluation and utility calculation of screening and interventions for prostate-related conditions in the general population.
Summary
Korean summary
이 연구는 일반인구집단을 대상으로 7개의 전립선 암 상태와 전립선 비대증, 발기부전상태의 효용값을 표준기회선택법을 이용하여 산출하였다. 전립선암 상태에 따라 평균 효용값은 0.281에서 0.779범위였다. 연구 결과는 전립선 관련 상태의 중재의 효용 계산이나 경제성 평가에 활용할 수 있을 것이다.
Lung Cancer Screening With Low-dose Chest Computed Tomography: Experience From Radon-contaminated Regions in Kazakhstan
Alexandra Panina, Dilyara Kaidarova, Zhamilya Zholdybay, Akmaral Ainakulova, Jandos Amankulov, Dias Toleshbayev, Zhanar Zhakenova, Arman Khozhayev
J Prev Med Public Health. 2022;55(3):273-279.   Published online April 14, 2022
DOI: https://doi.org/10.3961/jpmph.21.600
  • 5,062 View
  • 102 Download
  • 1 Web of Science
  • 3 Crossref
AbstractAbstract PDF
Objectives
The aim of this study was to present the baseline results of a pilot project conducted to evaluate the effectiveness of lung cancer screening using low-dose chest computed tomography (CT) in regions with excessive radon levels in the Republic of Kazakhstan.
Methods
In total, 3671 participants were screened by low-dose chest CT. Current, former, and never-smokers who resided in regions with elevated levels of radon in drinking water sources and indoor air, aged between 40 and 75 with no history of any cancer, and weighing less than 140 kg were included in the study. All lung nodules were categorized according to the American College of Radiology Lung Imaging Reporting and Data System (Lung-RADS 1.0).
Results
Overall, 614 (16.7%) participants had positive baseline CT findings (Lung-RADS categories 3 and 4). Seventy-four cancers were detected, yielding an overall cancer detection rate of 2.0%, with 10.8% (8/74) stage I and a predominance of stage III (59.4%; 44/74). Women never-smokers and men current smokers had the highest cancer detection rates, at 2.9% (12/412) and 6.1% (12/196), respectively. Compared to never-smokers, higher odds ratios (ORs) of lung cancer detection were found in smokers (OR,2.48; 95% confidence interval [CI], 1.52 to 4.05, p<0.001) and former smokers (OR, 2.32; 95% CI, 1.06 to 5.06, p=0.003). The most common histologic type of cancer was adenocarcinoma (58.1%).
Conclusions
Implementation of low-dose CT screening for lung cancer in regions with elevated radon levels is an effective method for both smokers and never-smokers.
Summary

Citations

Citations to this article as recorded by  
  • Lung cancer screening for never smokers: current evidence and future directions
    Kay Choong See
    Singapore Medical Journal.2024;[Epub]     CrossRef
  • Secondary prevention and treatment innovation of early stage non-small cell lung cancer: Impact on diagnostic-therapeutic pathway from a multidisciplinary perspective
    Giulia Pasello, Daniela Scattolin, Laura Bonanno, Francesca Caumo, Andrea Dell'Amore, Elena Scagliori, Mariaenrica Tinè, Fiorella Calabrese, Gaetano Benati, Matteo Sepulcri, Cristina Baiocchi, Michele Milella, Federico Rea, Valentina Guarneri
    Cancer Treatment Reviews.2023; 116: 102544.     CrossRef
  • Performance of Lung-RADS in different target populations: a systematic review and meta-analysis
    Yifei Mao, Jiali Cai, Marjolein A. Heuvelmans, Rozemarijn Vliegenthart, Harry J. M. Groen, Matthijs Oudkerk, Marleen Vonder, Monique D. Dorrius, Geertruida H. de Bock
    European Radiology.2023;[Epub]     CrossRef
Association Between Angiotensin II Receptor Blockers and the Risk of Lung Cancer Among Patients With Hypertension From the Korean National Health Insurance Service-National Health Screening Cohort
Sungji Moon, Hae-Young Lee, Jieun Jang, Sue K. Park
J Prev Med Public Health. 2020;53(6):476-486.   Published online November 3, 2020
DOI: https://doi.org/10.3961/jpmph.20.405
  • 4,333 View
  • 150 Download
  • 5 Crossref
AbstractAbstract PDFSupplementary Material
Objectives
The objective of this study was to estimate the risk of lung cancer in relation to angiotensin II receptor blocker (ARB) use among patients with hypertension from the Korean National Health Insurance Service-National Health Screening Cohort. Methods: We conducted a retrospective cohort study of patients with hypertension who started to take antihypertensive medications and had a treatment period of at least 6 months. We calculated the weighted hazard ratios (HRs) and their 95% confidence intervals (CIs) of lung cancer associated with ARB use compared with calcium channel blocker (CCB) use using inverse probability treatment weighting. Results: Among a total of 60 469 subjects with a median follow-up time of 7.8 years, 476 cases of lung cancer were identified. ARB use had a protective effect on lung cancer compared with CCB use (HR, 0.75; 95% CI, 0.59 to 0.96). Consistent findings were found in analyses considering patients who changed or discontinued their medication (HR, 0.50; 95% CI, 0.32 to 0.77), as well as for women (HR, 0.56; 95% CI, 0.34 to 0.93), patients without chronic obstructive pulmonary disease (HR, 0.75; 95% CI, 0.56 to 1.00), never-smokers (HR, 0.64; 95% CI, 0.42 to 0.99), and non-drinkers (HR, 0.69; 95% CI, 0.49 to 0.97). In analyses with different comparison antihypertensive medications, the overall protective effects of ARBs on lung cancer risk remained consistent. Conclusions: The results of the present study suggest that ARBs could decrease the risk of lung cancer. More evidence is needed to establish the causal effect of ARBs on the incidence of lung cancer.
Summary

Citations

Citations to this article as recorded by  
  • Association between Statins and Incidence of Cancer in Patients with Dyslipidemia Using Large-Scale Health Insurance Claims Data
    Ayako Maeda-Minami, Masayuki Takagi, Yasunari Mano, Hideki Ishikawa, Yutaka Matsuyama, Michihiro Mutoh
    Cancer Prevention Research.2023; 16(1): 37.     CrossRef
  • Angiotensin Receptor Blocker Associated with a Decreased Risk of Lung Cancer: An Updated Meta-Analysis
    Zexu Wang, Lingyun Wei, Cheng Yin, Wang Li, Bing Wan
    Journal of Personalized Medicine.2023; 13(2): 243.     CrossRef
  • The association between angiotensin receptor blockers and lung, bladder, and colon cancer development: A 10-year multicentric retrospective Lebanese study
    Yara G. Dagher, Sandra El Helou, Karen G. Haifa, Issam G. Chalhoub, Rita T. Boulos, Bachir Atallah, Fadi Nasr, Issam Kassab, Mirna N. Chahine
    Medicine.2023; 102(36): e34901.     CrossRef
  • Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers and Cancer Risk: An Updated Meta-Analysis of Observational Studies
    Kayeong Shin, Jiwoo Yang, Yeuni Yu, Eunjeong Son, Kihun Kim, Yun Hak Kim
    SSRN Electronic Journal .2022;[Epub]     CrossRef
  • The Effect of Local Renin Angiotensin System in the Common Types of Cancer
    Moudhi Almutlaq, Abir Abdullah Alamro, Hassan S. Alamri, Amani Ahmed Alghamdi, Tlili Barhoumi
    Frontiers in Endocrinology.2021;[Epub]     CrossRef
Brief Report
Estimating the Survival of Patients With Lung Cancer: What Is the Best Statistical Model?
Siavosh Abedi, Ghasem Janbabaei, Mahdi Afshari, Mahmood Moosazadeh, Masoumeh Rashidi Alashti, Akbar Hedayatizadeh-Omran, Reza Alizadeh-Navaei, Ehsan Abedini
J Prev Med Public Health. 2019;52(2):140-144.   Published online February 18, 2019
DOI: https://doi.org/10.3961/jpmph.17.090
  • 4,799 View
  • 132 Download
  • 6 Crossref
AbstractAbstract PDF
Objectives
Investigating the survival of patients with cancer is vitally necessary for controlling the disease and for assessing treatment methods. This study aimed to compare various statistical models of survival and to determine the survival rate and its related factors among patients suffering from lung cancer.
Methods
In this retrospective cohort, the cumulative survival rate, median survival time, and factors associated with the survival of lung cancer patients were estimated using Cox, Weibull, exponential, and Gompertz regression models. Kaplan-Meier tables and the log-rank test were also used to analyze the survival of patients in different subgroups.
Results
Of 102 patients with lung cancer, 74.5% were male. During the follow-up period, 80.4% died. The incidence rate of death among patients was estimated as 3.9 (95% confidence [CI], 3.1 to 4.8) per 100 person-months. The 5-year survival rate for all patients, males, females, patients with non-small cell lung carcinoma (NSCLC), and patients with small cell lung carcinoma (SCLC) was 17%, 13%, 29%, 21%, and 0%, respectively. The median survival time for all patients, males, females, those with NSCLC, and those with SCLC was 12.7 months, 12.0 months, 16.0 months, 16.0 months, and 6.0 months, respectively. Multivariate analyses indicated that the hazard ratios (95% CIs) for male sex, age, and SCLC were 0.56 (0.33 to 0.93), 1.03 (1.01 to 1.05), and 2.91 (1.71 to 4.95), respectively.
Conclusions
Our results showed that the exponential model was the most precise. This model identified age, sex, and type of cancer as factors that predicted survival in patients with lung cancer.
Summary

Citations

Citations to this article as recorded by  
  • Primary and Acquired Resistance against Immune Check Inhibitors in Non-Small Cell Lung Cancer
    Qinying Sun, Xiangzhen Wei, Zhonglin Wang, Yan Zhu, Weiying Zhao, Yuchao Dong
    Cancers.2022; 14(14): 3294.     CrossRef
  • Impact of Residential Concentration of PM2.5 Analyzed as Time-Varying Covariate on the Survival Rate of Lung Cancer Patients: A 15-Year Hospital-Based Study in Upper Northern Thailand
    Nawapon Nakharutai, Patrinee Traisathit, Natthapat Thongsak, Titaporn Supasri, Pimwarat Srikummoon, Salinee Thumronglaohapun, Phonpat Hemwan, Imjai Chitapanarux
    International Journal of Environmental Research and Public Health.2022; 19(8): 4521.     CrossRef
  • Risk factors of inability to live independently in the course of lung cancer
    Marek Tradecki, Jolanta Ziółkowska, Roma Roemer-Ślimak, Grzegorz Mazur, Aleksandra Butrym
    Postępy Higieny i Medycyny Doświadczalnej.2022; 76(1): 402.     CrossRef
  • Deep learning-based tumor microenvironment segmentation is predictive of tumor mutations and patient survival in non-small-cell lung cancer
    Alicja Rączkowska, Iwona Paśnik, Michał Kukiełka, Marcin Nicoś, Magdalena A. Budzinska, Tomasz Kucharczyk, Justyna Szumiło, Paweł Krawczyk, Nicola Crosetto, Ewa Szczurek
    BMC Cancer.2022;[Epub]     CrossRef
  • Biology of NSCLC: Interplay between Cancer Cells, Radiation and Tumor Immune Microenvironment
    Slavisa Tubin, Mohammad K. Khan, Seema Gupta, Branislav Jeremic
    Cancers.2021; 13(4): 775.     CrossRef
  • Immune Infiltration Profiling in Nonsmall Cell Lung Cancer and Their Clinical Significance: Study Based on Gene Expression Measurements
    Fangyao Chen, Yuhui Yang, Yaling Zhao, Leilei Pei, Hong Yan
    DNA and Cell Biology.2019; 38(11): 1387.     CrossRef
Original Articles
The Risk of Colorectal Cancer After Cholecystectomy or Appendectomy: A Population-based Cohort Study in Korea
Joonki Lee, Sunho Choe, Ji Won Park, Seung-Yong Jeong, Aesun Shin
J Prev Med Public Health. 2018;51(6):281-288.   Published online October 29, 2018
DOI: https://doi.org/10.3961/jpmph.18.105
  • 7,593 View
  • 219 Download
  • 19 Crossref
AbstractAbstract AbstractSummary PDFSupplementary Material
Objectives
We investigated the association between cholecystectomy or appendectomy and the subsequent risk of colorectal cancer (CRC) in the Korean population.
Methods
A retrospective cohort study was conducted with the National Health Insurance Service–National Sample Cohort of Korea; this sample was followed up from January 1, 2002, until the date of CRC incidence, loss to follow-up, or December 31, 2015. The exposure status of cholecystectomy and appendectomy was treated as a time-varying covariate. The calculated risk of CRC was stratified by follow-up period, and the association between these surgical procedures and CRC was investigated by a Cox regression model applying appropriate lag periods.
Results
A total of 707 663 individuals were identified for analysis. The study population was followed up for an average of 13.66 years, and 4324 CRC cases were identified. The hazard ratio (HR) of CRC was elevated in the first year after cholecystectomy (HR, 1.71; 95% confidence interval [CI], 1.01 to 2.89) and in the first year and 2-3 years after appendectomy (HR, 4.22; 95% CI, 2.87 to 6.20; HR, 2.34; 95% CI, 1.36 to 4.03, respectively). The HRs of CRC after applying 1 year of lag after cholecystectomy and 3 years of lag after appendectomy were 0.80 (95% CI, 0.57 to 1.13) and 0.77 (95% CI, 0.51 to 1.16), respectively.
Conclusions
The risk of CRC increased in the first year after cholecystectomy and appendectomy, implying the possibility of bias. When appropriate lag periods after surgery were applied, no association was found between cholecystectomy or appendectomy and CRC.
Summary
Korean summary
본 연구는 담낭절제술, 충수돌기절제술 후 대장암의 발생위험에 관한 연구로 국민건강보험공단 표본코호트자료를 사용한 후향적코호트 연구이다. 총 707 663명을 대상으로 연구를 진행하였으며, 담낭절제술을 시행한 환자들은 수술 후 1년 이내에서 대장암의 위험도가 유의하게 증가하였으나 이후 관련성을 보이지 않았고, 충수돌기절제술을 시행한 환자들은 수술 후 1년, 2~3년에서 유의하게 위험도가 증가하였으나, 이후에는 관련성을 보이지 않았다. 이 결과는 역인과관계의 가능성을 시사하며 이것을 고려하였을 때, 담낭절제술과 충수돌기절제술은 대장암의 발생위험과의 연관성을 보이지 않았다.

Citations

Citations to this article as recorded by  
  • Beyond a vestigial organ: effects of the appendix on gut microbiome and colorectal cancer
    Daniel Ren Yi Yap, Rashid N Lui, Jens Samol, Joanne Ngeow, Joseph JY Sung, Sunny H Wong
    Journal of Gastroenterology and Hepatology.2024;[Epub]     CrossRef
  • The Appendix Orchestrates T-Cell Mediated Immunosurveillance in Colitis-Associated Cancer
    Maxime K. Collard, Julien Tourneur-Marsille, Mathieu Uzzan, Miguel Albuquerque, Maryline Roy, Anne Dumay, Jean-Noël Freund, Jean-Pierre Hugot, Nathalie Guedj, Xavier Treton, Yves Panis, Eric Ogier-Denis
    Cellular and Molecular Gastroenterology and Hepatology.2023; 15(3): 665.     CrossRef
  • Risk of colorectal cancer in patients with appendicitis over the age of 40 years
    Mei Sze Lee, Alben Thomas, John F. Pearson, Rachel Purcell, Francis Frizelle, Tamara Glyn
    Colorectal Disease.2023; 25(4): 624.     CrossRef
  • Risk of colorectal cancer after appendectomy: A systematic review and meta‐analysis
    Zhuhui Liu, Xinyue Ma, Chunqi Zhu, Jing‐Yuan Fang
    Journal of Gastroenterology and Hepatology.2023; 38(3): 350.     CrossRef
  • Does postcholecystectomy increase the risk of colorectal cancer?
    Zhenyu Dong, Ruixian Shi, Pengda Li, Xiaobiao Song, Fan Dong, Jianmin Zhu, Riga Wu, Zhi Liang, Mingyue Du, Jijun Wang, Zhigang Yang
    Frontiers in Microbiology.2023;[Epub]     CrossRef
  • The association between prescription drugs and colorectal cancer prognosis: a nationwide cohort study using a medication-wide association study
    Hyeong-Taek Woo, Seung-Yong Jeong, Aesun Shin
    BMC Cancer.2023;[Epub]     CrossRef
  • Cholecystectomy Increases the Risk of Type 2 Diabetes in the Korean Population
    Ji Hye Huh, Kyong Joo Lee, Yun Kyung Cho, Shinje Moon, Yoon Jung Kim, Eun Roh, Kyung-do Han, Dong Hee Koh, Jun Goo Kang, Seong Jin Lee, Sung-Hee Ihm
    Annals of Surgery.2023; 278(2): e264.     CrossRef
  • No association between cholecystectomy and risk of colorectal cancer: a meta-analysis of cohort studies
    Lulin Yu, Wenjing Liu, Yici Yan, Yu Jiang, Xin Gao, Shanming Ruan
    International Journal of Colorectal Disease.2023;[Epub]     CrossRef
  • Operational Definitions of Colorectal Cancer in the Korean National Health Insurance Database
    Hyeree Park, Yu Rim Kim, Yerin Pyun, Hyundeok Joo, Aesun Shin
    Journal of Preventive Medicine and Public Health.2023; 56(4): 312.     CrossRef
  • Factors influencing advanced colorectal neoplasm anatomic site distribution in China: An epidemiological study based on colorectal cancer screening data
    Kailong Zhao, Hongzhou Li, Baofeng Zhang, Wenwen Pang, Suying Yan, Xinzhu Zhao, Xinyu Liu, Wanting Wang, Qiurong Han, Yao Yao, Tianhao Chu, Zhiqiang Feng, Qinghuai Zhang, Chunze Zhang
    Cancer Medicine.2023; 12(24): 22252.     CrossRef
  • Colorectal cancer risk following appendectomy: a pooled analysis of three large prospective cohort studies
    Joseph A. Rothwell, Nagisa Mori, Fanny Artaud, Agnès Fournier, Marco Conte, Marie‐Christine Boutron‐Ruault, Simon S. M. Chan, Marc J. Gunter, Neil Murphy, Gianluca Severi
    Cancer Communications.2022; 42(5): 486.     CrossRef
  • Appendectomy and the subsequent risk of cancer: A prospective population-based cohort study with long follow-up
    A.L. van den Boom, B.D.A. Lavrijssen, J. Fest, M.A. Ikram, B.H. Stricker, C.H.J. van Eijck, R. Ruiter
    Cancer Epidemiology.2022; 77: 102120.     CrossRef
  • Cholecystectomy-induced secondary bile acids accumulation ameliorates colitis through inhibiting monocyte/macrophage recruitment
    Yun Liu, Jun Xu, Xinhua Ren, Yu Zhang, Ziliang Ke, Jianhua Zhou, Yang Wang, Yifan Zhang, Yulan Liu
    Gut Microbes.2022;[Epub]     CrossRef
  • A Review of Colorectal Cancer in Terms of Epidemiology, Risk Factors, Development, Symptoms and Diagnosis
    Tomasz Sawicki, Monika Ruszkowska, Anna Danielewicz, Ewa Niedźwiedzka, Tomasz Arłukowicz, Katarzyna E. Przybyłowicz
    Cancers.2021; 13(9): 2025.     CrossRef
  • Increased Risk of Major Depressive Disorder After Cholecystectomy: A Nationwide Population-Based Cohort Study in Korea
    Eun Hyo Jin, Kyungdo Han, Dong Ho Lee, Cheol Min Shin, Joo Hyun Lim, Hyuk Yoon, Nayoung Kim
    Clinical and Translational Gastroenterology.2021; 12(4): e00339.     CrossRef
  • Evaluating the distribution of the locations of colorectal cancer after appendectomy and cholecystectomy
    Szabolcs Ábrahám, Tibor Németh, Ria Benkő, Mária Matuz, Aurél Ottlakán, Dániel Váczi, Attila Paszt, Zsolt Simonka, György Lázár
    World Journal of Surgical Oncology.2020;[Epub]     CrossRef
  • Smoking status before and after colorectal cancer diagnosis and mortality in Korean men: A population‐based cohort study
    Doeun Jang, Sunho Choe, Ji Won Park, Seung‐Yong Jeong, Aesun Shin
    Cancer Medicine.2020; 9(24): 9641.     CrossRef
  • Prognosis of Patients with Colorectal Cancer with Diabetes According to Medication Adherence: A Population-Based Cohort Study
    Sunho Choe, Joonki Lee, Ji Won Park, Seung-Yong Jeong, Young Min Cho, Byung-Joo Park, Aesun Shin
    Cancer Epidemiology, Biomarkers & Prevention.2020; 29(6): 1120.     CrossRef
  • Safety and efficacy of laparoscopic cholecystectomy in preschool children
    Sajad Ahmad Wani, Gowher Nazir Mufti, Nisar Ahmad Bhat, Aejaz Ahsan Baba, Faheem Andrabi, Mudasir Hamid, Shahid Shazad
    Journal of Pediatric Endoscopic Surgery.2019; 1(3): 119.     CrossRef
Demographic and Survivorship Disparities in Non–muscle-invasive Bladder Cancer in the United States
Munseok Seo, James R. Langabeer II
J Prev Med Public Health. 2018;51(5):242-247.   Published online August 23, 2018
DOI: https://doi.org/10.3961/jpmph.18.092
  • 5,745 View
  • 155 Download
  • 13 Crossref
AbstractAbstract PDF
Objectives
To examine survivorship disparities in demographic factors and risk status for non–muscle-invasive bladder cancer (NMIBC), which accounts for more than 75% of all urinary bladder cancers, but is highly curable with early identification and treatment. Methods: We used the US National Cancer Institute’s Surveillance, Epidemiology, and End Results registries over a 19-year period (1988-2006) to examine survivorship disparities in age, sex, race/ethnicity, and marital status of patients and risk status classified by histologic grade, stage, size of tumor, and number of multiple primary tumors among NMIBC patients (n=29 326). We applied Kaplan-Meier (K-M) and Cox proportional hazard methods for survival analysis. Results: Among all urinary bladder cancer patients, the majority of NMIBCs were in male (74.1%), non-Latino white (86.7%), married (67.8%), and low-risk (37.6%) to intermediate-risk (44.8%) patients. The mean age was 68 years. Survivorship (in median life years) was highest for non-Latino white (5.4 years), married (5.4 years), and low-risk (5.7 years) patients (K-M analysis, p<0.001). We found significantly lower survivorship for elderly, male (female hazard ratio [HR], 0.96), Latino (HR, 1.20), and unmarried (married HR, 0.93) patients. Conclusions: Survivorship disparities were ubiquitous across age, sex, race/ethnicity, and marital status groups. Non-white, unmarried, and elderly patients had significantly shorter survivorship. The implications of these findings include the need for a heightened focus on health policy and more organized efforts to improve access to care in order to increase the chances of survival for all patients.
Summary

Citations

Citations to this article as recorded by  
  • Disparities in the prevalence and management of high-risk non-muscle invasive bladder cancer
    Angela Estevez, Sumedh Kaul, Aaron Fleishman, Ruslan Korets, Peter Chang, Andrew Wagner, Joaquim Bellmunt, Aria F. Olumi, Heidi Rayala, Boris Gershman
    Urologic Oncology: Seminars and Original Investigations.2023; 41(5): 255.e15.     CrossRef
  • Intermediate and high-risk non-muscle-invasive bladder cancer: an overview of epidemiology, burden, and unmet needs
    Kristin Grabe-Heyne, Christof Henne, Paramananthan Mariappan, Götz Geiges, Johannes Pöhlmann, Richard F. Pollock
    Frontiers in Oncology.2023;[Epub]     CrossRef
  • Treatment Outcomes of High-Risk Non-Muscle Invasive Bladder Cancer (HR-NMIBC) in Real-World Evidence (RWE) Studies: Systematic Literature Review (SLR)
    Mihaela Georgiana Musat, Christina Soeun Kwon, Elizabeth Masters, Slaven Sikirica, Debduth B Pijush, Anna Forsythe
    ClinicoEconomics and Outcomes Research.2022; Volume 14: 35.     CrossRef
  • Management, Surveillance Patterns, and Costs Associated With Low-Grade Papillary Stage Ta Non–Muscle-Invasive Bladder Cancer Among Older Adults, 2004-2013
    Kelly K. Bree, Yong Shan, Patrick J. Hensley, Niyati Lobo, Chengrui Hu, Douglas S. Tyler, Karim Chamie, Ashish M. Kamat, Stephen B. Williams
    JAMA Network Open.2022; 5(3): e223050.     CrossRef
  • Gender Disparities in Bladder Cancer-Specific Survival in High Poverty Areas Utilizing Ohio Cancer Incidence Surveillance System (OCISS)
    Laura Bukavina, Megan Prunty, Kirtishri Mishra, Helen Sun, David Sheyn, Britt Conroy, Amr Mahran, Gregory MacLennan, Fredrick Schumacher, Lee Ponsky, Sarah Markt
    Urology.2021; 151: 163.     CrossRef
  • Comparison of survival in elderly patients treated with uretero-cutaneostomy or ileal conduit after radical cystectomy
    Shang Huang, Hanzhong Chen, Teng Li, Xiaoyong Pu, Jiumin Liu, Xuecheng Bi
    BMC Geriatrics.2021;[Epub]     CrossRef
  • Non-Muscular Invasive Bladder Cancer: Re-envisioning Therapeutic Journey from Traditional to Regenerative Interventions
    Kuan-Wei Shih, Wei-Chieh Chen, Ching-Hsin Chang, Ting-En Tai, Jeng-Cheng Wu, Andy C. Huang, Ming-Che Liu
    Aging and disease.2021; 12(3): 868.     CrossRef
  • The impact of the social construct of race on outcomes among bacille Calmette‐Guérin‐treated patients with high‐risk non‐muscle–invasive bladder cancer in an equal‐access setting
    Corinne Lawler, Lin Gu, Lauren E. Howard, Brandee Branche, Emily Wiggins, Aditya Srinivasan, Meagan L. Foster, Zachary Klaassen, Amanda M. De Hoedt, Jeffrey R. Gingrich, Dan Theodorescu, Stephen J. Freedland, Stephen B. Williams
    Cancer.2021; 127(21): 3998.     CrossRef
  • Effect of Intravesical Chemotherapy on the Survival of Patients with Non-Muscle-Invasive Bladder Cancer Undergoing Transurethral Resection: A Retrospective Cohort Study Among Older Adults
    Ashis K. Das, Devi K. Mishra, Saji S. Gopalan
    The Open Urology & Nephrology Journal.2021; 14(1): 20.     CrossRef
  • Marital Status and Prognostic Nomogram for Bladder Cancer With Distant Metastasis: A SEER-Based Study
    Liangjun Tao, Xinyuan Pan, Lixiang Zhang, Jiawei Wang, Zican Zhang, Li Zhang, Chaozhao Liang
    Frontiers in Oncology.2020;[Epub]     CrossRef
  • Back pain following instillations of BCG for superficial bladder cancer is not a reactive complication: review of 30 Mycobacterium bovis BCG vertebral osteomyelitis cases
    Simon Cadiou, Omar Al Tabaa, Chi-Duc Nguyen, Marine Faccin, Raphaël Guillin, Matthieu Revest, Pascal Guggenbuhl, Eric Houvenagel, Edouard Pertuiset, Guillaume Coiffier
    Clinical Rheumatology.2019; 38(6): 1773.     CrossRef
  • Does Health Insurance Modify the Association Between Race and Cancer-Specific Survival in Patients with Urinary Bladder Malignancy in the U.S.?
    Juliana Morales, Aaron Malles, Marrell Kimble, Pura Rodriguez de la Vega, Grettel Castro, Alan M. Nieder, Noël C. Barengo
    International Journal of Environmental Research and Public Health.2019; 16(18): 3393.     CrossRef
  • Чи може бути гормонотерапія елементом комбінованого радикального лікування хворих на низькодиференційований рак сечового міхура?
    P. G. Yakovlev
    Шпитальна хірургія. Журнал імені Л. Я. Ковальчука.2019; (3): 75.     CrossRef
Family Members of Cancer Patients in Korea Are at an Increased Risk of Medically Diagnosed Depression
Youngdae Cho, Yongwoo Jeon, Sung-In Jang, Eun-Cheol Park
J Prev Med Public Health. 2018;51(2):100-108.   Published online February 19, 2018
DOI: https://doi.org/10.3961/jpmph.17.166
  • 6,342 View
  • 220 Download
  • 9 Crossref
AbstractAbstract PDFSupplementary Material
Objectives
Family members are often cancer patients’ primary source of social and emotional support and make a major contribution to how well patients manage their illness. We compared the prevalence of depression in the family members of cancer patients and the general population. Methods: This study used the data from the fourth, fifth, and sixth rounds of the Korea National Health and Nutrition Examination Survey. The variable of interest was the presence of a cohabitating cancer patient in the family and the dependent variable was the presence of diagnosed depression. Results: The odds of having medically diagnosed depression in those with a cohabitating cancer patient in the family were significantly higher than among those who did not have cancer patients in their families (odds ratio [OR], 1.56; 95% confidence interval [CI], 1.12 to 2.17; p=0.009). The OR for females was 1.59, and this increase was statistically significant (95% CI, 1.09 to 2.31; p=0.02). Conclusions: We need to invest more effort into diagnosing and managing depression in the family members of cancer patients. This will have an impact both on their quality of life and on the well-being of patients, as supporters and caregivers play an instrumental role in helping patients manage their illness.
Summary

Citations

Citations to this article as recorded by  
  • Quality of Life in Caregivers of Cancer Patients: A Literature Review
    María Dolores Guerra-Martín, María Del Rocío Casado-Espinosa, Yelena Gavira-López, Cristina Holgado-Castro, Inmaculada López-Latorre, Álvaro Borrallo-Riego
    International Journal of Environmental Research and Public Health.2023; 20(2): 1570.     CrossRef
  • Association between changes in having of cancer patients in the family and depression: A longitudinal panel study
    Yun Seo Jang, Na-Young Yoon, Kyungduk Hurh, Eun-Cheol Park, Min Jin Ha
    Journal of Affective Disorders.2023; 333: 482.     CrossRef
  • Determinants of Quality of Life in Family Caregivers of Patients With Leukemia: A Cross-Sectional Study
    Nahla M. Al Ali, Amjad Eid, Nabela Aljada
    SAGE Open.2023;[Epub]     CrossRef
  • Consistency between patients and families in recognizing cancer chemotherapy side effects: A questionnaire survey
    Fukuko Horio, Tokunori Ikeda, Yurimi Arake, Nodoka Kawashima, Erina Eto, Makoto Matsukura, Isao Fujii, Yuji Uchida
    Cancer Reports.2022;[Epub]     CrossRef
  • Early-Career Physician Burnout
    Leelach Rothschild, Ciera Ward
    Anesthesiology Clinics.2022; 40(2): 315.     CrossRef
  • Informal caregivers’ quality of life and management strategies following the transformation of their cancer caregiving role: A qualitative systematic review
    Yingying Cai, Alison Simons, Samantha Toland, Junfeng Zhang, Kexin Zheng
    International Journal of Nursing Sciences.2021; 8(2): 227.     CrossRef
  • Risk of major depressive disorder in spouses of cancer patients in Japan: A cohort study using health insurance‐based claims data
    Tatsuo Akechi, Izumi Mishiro, Shinji Fujimoto, Katsuhito Murase
    Psycho-Oncology.2020; 29(7): 1224.     CrossRef
  • Caregiving experiences of Korean family caregivers of cancer patients: An integrative literature review
    Eunice E. Lee, Shin‐Young Lee
    Psycho-Oncology.2020; 29(10): 1486.     CrossRef
  • The Measure of the Family Caregivers’ Experience
    Mercedes Guilabert, Paloma Amil, Asunción González-Mestre, Esther Gil-Sánchez, Anna Vila, Joan Contel, Juan Ansotegui, Olga Solas, Ma Bacigalupe, Paloma Fernández-Cano, Marisa Arteagoitia, José Mira
    International Journal of Environmental Research and Public Health.2018; 15(9): 2040.     CrossRef
A Survival Analysis of Gastric or Colorectal Cancer Patients Treated With Surgery: Comparison of Capital and a Non-capital City
Nam-Soo Hong, Kyeong Soo Lee, Sin Kam, Gyu Seog Choi, Oh Kyoung Kwon, Dong Hee Ryu, Sang Won Kim
J Prev Med Public Health. 2017;50(5):283-293.   Published online July 3, 2017
DOI: https://doi.org/10.3961/jpmph.17.043
  • 5,691 View
  • 223 Download
  • 3 Crossref
AbstractAbstract PDFSupplementary Material
Objectives
The objective of the present study was to compare prognosis of patients with gastric or colorectal cancer according to places where they received surgeries. Methods: The cancer patients underwent surgeries in sampled hospitals located in Daegu were matched 1:1 to the patients who visited sampled hospitals in Seoul using propensity score method. After the occurrences of death were examined, Kaplan-Meier method was used for survival analysis and the log-rank test was performed to compare the survival curves. Results: A total of six out of 291 gastric cancer patients who had surgeries in Daegu died (2.1%) and ten deaths (3.4%) occurred from patients went Seoul hospitals. Out of 84 gastric cancer patients who had chemotherapy after surgeries in Daegu, 13 (15.5%) patients died while 18 (21.4%) deaths occurred among patients underwent surgeries in Seoul. Six deaths (6.9%) out of 87 colorectal cancer patients who had surgeries in Daegu were reported. Five patients (5.7%) died among the patients underwent surgeries in Seoul. Among the colorectal cancer patients with chemotherapy after surgeries, 13 patients (12.4%) who visited hospitals in Daegu and 14 (13.3%) patients who used medical centers in Seoul died. There were no significant differences according to places where patients used medical services. Conclusions: The result of this study is expected to be used as basic data for policy making to resolve centralization problem of cancer patients and to help patients to make rational choices in selection of medical centers.
Summary

Citations

Citations to this article as recorded by  
  • Domestic medical travel from non-Seoul regions to Seoul for initial breast cancer treatment: a nationwide cohort study
    Jae Ho Jeong, Jinhong Jung, Hee Jeong Kim, Jong Won Lee, Beom-Seok Ko, Byung Ho Son, Kyung Hae Jung, Il Yong Chung
    Annals of Surgical Treatment and Research.2023; 104(2): 71.     CrossRef
  • MCR1 and KPC2 Co-producing Klebsiella pneumoniae Bacteremia: First Case in Korea
    Ji Young Park, Sang Taek Heo, Ki Tae Kwon, Do Young Song, Kwang Jun Lee, Ji Ae Choi
    Infection & Chemotherapy.2019; 51(4): 399.     CrossRef
  • The Effect of Residential Area and Hospital Bed Size on the Use of Hospital in Other Regions for Cancer Inpatients
    Sung-Soo Kim
    Journal of Health Informatics and Statistics.2018; 43(1): 18.     CrossRef
Reviews
Breast Density and Risk of Breast Cancer in Asian Women: A Meta-analysis of Observational Studies
Jong-Myon Bae, Eun Hee Kim
J Prev Med Public Health. 2016;49(6):367-375.   Published online October 21, 2016
DOI: https://doi.org/10.3961/jpmph.16.054
  • 14,830 View
  • 308 Download
  • 43 Crossref
AbstractAbstract PDF
Objectives
The established theory that breast density is an independent predictor of breast cancer risk is based on studies targeting white women in the West. More Asian women than Western women have dense breasts, but the incidence of breast cancer is lower among Asian women. This meta-analysis investigated the association between breast density in mammography and breast cancer risk in Asian women.
Methods
PubMed and Scopus were searched, and the final date of publication was set as December 31, 2015. The effect size in each article was calculated using the interval-collapse method. Summary effect sizes (sESs) and 95% confidence intervals (CIs) were calculated by conducting a meta-analysis applying a random effect model. To investigate the dose-response relationship, random effect dose-response meta-regression (RE-DRMR) was conducted.
Results
Six analytical epidemiology studies in total were selected, including one cohort study and five case-control studies. A total of 17 datasets were constructed by type of breast density index and menopausal status. In analyzing the subgroups of premenopausal vs. postmenopausal women, the percent density (PD) index was confirmed to be associated with a significantly elevated risk for breast cancer (sES, 2.21; 95% CI, 1.52 to 3.21; I2=50.0%). The RE-DRMR results showed that the risk of breast cancer increased 1.73 times for each 25% increase in PD in postmenopausal women (95% CI, 1.20 to 2.47).
Conclusions
In Asian women, breast cancer risk increased with breast density measured using the PD index, regardless of menopausal status. We propose the further development of a breast cancer risk prediction model based on the application of PD in Asian women.
Summary

Citations

Citations to this article as recorded by  
  • Intelligent scoring system based on dynamic optical breast imaging for early detection of breast cancer
    Yaoyao Li, Yipei Zhang, Qiang Yu, Chenglong He, Xiguo Yuan
    Biomedical Optics Express.2024; 15(3): 1515.     CrossRef
  • Polygenic risk scores for prediction of breast cancer in Korean women
    Yon Ho Jee, Weang-Kee Ho, Sohee Park, Douglas F Easton, Soo-Hwang Teo, Keum Ji Jung, Peter Kraft
    International Journal of Epidemiology.2023; 52(3): 796.     CrossRef
  • Estimating Age-Specific Mean Sojourn Time of Breast Cancer and Sensitivity of Mammographic Screening by Breast Density among Korean Women
    Eunji Choi, Mina Suh, So-Youn Jung, Kyu-Won Jung, Sohee Park, Jae Kwan Jun, Kui Son Choi
    Cancer Research and Treatment.2023; 55(1): 136.     CrossRef
  • Current Trends in the Utilization of Preoperative Breast Magnetic Resonance Imaging Among Women With Newly Diagnosed Breast Cancer
    I-Wen Pan, Tina W.F. Yen, Isabelle Bedrosian, Ya-Chen Tina Shih
    JCO Oncology Practice.2023; 19(7): 446.     CrossRef
  • International Interobserver Variability of Breast Density Assessment
    Leah H. Portnow, Lina Choridah, Kardinah Kardinah, Triwulan Handarini, Ruud Pijnappel, Adriana M.J. Bluekens, Lucien E.M. Duijm, Peter K. Schoub, Pamela S. Smilg, Liat Malek, Jessica W.T. Leung, Sughra Raza
    Journal of the American College of Radiology.2023; 20(7): 671.     CrossRef
  • Deep Learning Analysis of Mammography for Breast Cancer Risk Prediction in Asian Women
    Hayoung Kim, Jihe Lim, Hyug-Gi Kim, Yunji Lim, Bo Kyoung Seo, Min Sun Bae
    Diagnostics.2023; 13(13): 2247.     CrossRef
  • The diagnostic accuracy of mammography and ultrasonography for recurrent breast cancer after breast conserving treatment
    Piyakan Pathanasethpong, Supajit Nawapun, Payia Chadbunchachai, Ongart Somintara, Chaiwat Apivatanasiri, Arunnit Boonrod
    European Journal of Radiology Open.2023; 11: 100514.     CrossRef
  • Fine-needle aspiration biopsy possibilities in studying the molecular genetic landscape of breast tissue
    V.  V.  Rodionov, O.  V.  Burmenskaya, V.  V.  Kometova, A.  A.  Smetnik, M.  V.  Rodionova, D.  Yu.  Trofimov, L.  A.  Ashrafyan, G.  T.  Sukhikh
    Tumors of female reproductive system.2023; 19(4): 16.     CrossRef
  • miR-146a Enhances the Sensitivity of Breast Cancer Cells to Paclitaxel by Downregulating IRAK1
    Yalun Li, Weilong Li, Jun Lin, Chunjing Lv, Guangdong Qiao
    Cancer Biotherapy and Radiopharmaceuticals.2022; 37(8): 624.     CrossRef
  • Current status of AYA-generation breast cancer: trends worldwide and in Japan
    Manabu Futamura, Kazuhiro Yoshida
    International Journal of Clinical Oncology.2022; 27(1): 16.     CrossRef
  • A Machine Learning Ensemble Based on Radiomics to Predict BI-RADS Category and Reduce the Biopsy Rate of Ultrasound-Detected Suspicious Breast Masses
    Matteo Interlenghi, Christian Salvatore, Veronica Magni, Gabriele Caldara, Elia Schiavon, Andrea Cozzi, Simone Schiaffino, Luca Alessandro Carbonaro, Isabella Castiglioni, Francesco Sardanelli
    Diagnostics.2022; 12(1): 187.     CrossRef
  • Global guidelines for breast cancer screening: A systematic review
    Wenhui Ren, Mingyang Chen, Youlin Qiao, Fanghui Zhao
    The Breast.2022; 64: 85.     CrossRef
  • Utility of U-Net for the objective segmentation of the fibroglandular tissue region on clinical digital mammograms
    Mika Yamamuro, Yoshiyuki Asai, Naomi Hashimoto, Nao Yasuda, Hiorto Kimura, Takahiro Yamada, Mitsutaka Nemoto, Yuichi Kimura, Hisashi Handa, Hisashi Yoshida, Koji Abe, Masahiro Tada, Hitoshi Habe, Takashi Nagaoka, Seiun Nin, Kazunari Ishii, Yohan Kondo
    Biomedical Physics & Engineering Express.2022; 8(4): 045016.     CrossRef
  • Breast Cancer Disparities in Asian Women: The Need for Disaggregated Research
    Lauren Fane, Tithi Biswas, Charulata Jindal, Yuk Ming Choi, Jimmy T. Efird
    International Journal of Environmental Research and Public Health.2022; 19(16): 9790.     CrossRef
  • Vertical Breast Displacement in Asian Women During Exercise: influence of Bra Type, Size and Different Parts of the Breast
    Xinyang Sheng, Xiaona Chen, Mark John Lake
    Fibres & Textiles in Eastern Europe.2022; 30(3): 1.     CrossRef
  • Studies of parenchymal texture added to mammographic breast density and risk of breast cancer: a systematic review of the methods used in the literature
    Akila Anandarajah, Yongzhen Chen, Graham A. Colditz, Angela Hardi, Carolyn Stoll, Shu Jiang
    Breast Cancer Research.2022;[Epub]     CrossRef
  • Robust breast cancer detection in mammography and digital breast tomosynthesis using an annotation-efficient deep learning approach
    William Lotter, Abdul Rahman Diab, Bryan Haslam, Jiye G. Kim, Giorgia Grisot, Eric Wu, Kevin Wu, Jorge Onieva Onieva, Yun Boyer, Jerrold L. Boxerman, Meiyun Wang, Mack Bandler, Gopal R. Vijayaraghavan, A. Gregory Sorensen
    Nature Medicine.2021; 27(2): 244.     CrossRef
  • Association between changes in mammographic density category and the risk of breast cancer: A nationwide cohort study in East‐Asian women
    Soyeoun Kim, Boyoung Park
    International Journal of Cancer.2021; 148(11): 2674.     CrossRef
  • Dense Breast Notification Laws’ Association With Outcomes in the US Population: A Cross-Sectional Study
    Nancy R. Kressin, Tracy A. Battaglia, Jolie B. Wormwood, Priscilla J. Slanetz, Christine M. Gunn
    Journal of the American College of Radiology.2021; 18(5): 685.     CrossRef
  • Breast Cancer Lesion Detection and Classification in mammograms using Deep Neural
    A R J Silalahi
    IOP Conference Series: Materials Science and Engineering.2021; 1115(1): 012018.     CrossRef
  • Cancer Progress and Priorities: Breast Cancer
    Serena C. Houghton, Susan E. Hankinson
    Cancer Epidemiology, Biomarkers & Prevention.2021; 30(5): 822.     CrossRef
  • Enhancing the Screening Efficiency of Breast Cancer by Combining Conventional Medical Imaging Examinations With Circulating Tumor Cells
    Yang Gao, Wan-Hung Fan, Chaohui Duan, Wenhe Zhao, Jun Zhang, Xixiong Kang
    Frontiers in Oncology.2021;[Epub]     CrossRef
  • Comparison of the diagnostic performances of circulating tumor cells and the serum tumor markers CEA, CA125, and CA15-3 for breast cancer: a retrospective case-control study
    Yi Luan, Jie Wei, Ke Wang, Donghao Cai, Xiaohong Luo, Wanhung Fan, Haijiang Wang, Chaohui Duan
    Journal of Bio-X Research.2021; 4(2): 60.     CrossRef
  • Meme kanseri olan Türk kadın hastalarda meme dansitesinin klinik ve patolojik bulgularla ilişkileri
    Nihan TURHAN, Dilek YILMAZ, Levent YEŞİLYURT
    Pamukkale Medical Journal.2021;[Epub]     CrossRef
  • Evidence and assessment of parenchymal patterns of ultrasonography for breast cancer detection among Chinese women: a cross-sectional study
    Zhongtao Bao, Yanchun Zhao, Shuqiang Chen, Xiaoyu Chen, Xiang Xu, Linglin Wei, Ling Chen
    BMC Medical Imaging.2021;[Epub]     CrossRef
  • The Relationship Between Breast Density Change During Menopause and the Risk of Breast Cancer in Korean Women
    Danbee Kang, Ji-Yeon Kim, Ji-Young Kim, Han Song Mun, Sook Ja Yoon, Jieun Lee, Gayeon Han, Young-Hyuck Im, Soo-Young Shin, Se Kyung Lee, Jong-Han Yu, Kyung-Hyun Lee, Mincheol Kim, Dohyun Park, Yoon-Ho Choi, Ok Soon Jeong, Jean Hyoung Lee, Se Yong Jekal, J
    Cancer Prevention Research.2021; 14(12): 1119.     CrossRef
  • Feasibility of Portable Microwave Imaging Device for Breast Cancer Detection
    Mio Adachi, Tsuyoshi Nakagawa, Tomoyuki Fujioka, Mio Mori, Kazunori Kubota, Goshi Oda, Takamaro Kikkawa
    Diagnostics.2021; 12(1): 27.     CrossRef
  • Primary prevention of breast cancer
    V.F. Levshin
    Profilakticheskaya meditsina.2021; 24(11): 117.     CrossRef
  • Immigration history, lifestyle characteristics, and breast density in the Vietnamese American Women’s Health Study: a cross-sectional analysis
    Eunjung Lee, Namphuong Doanvo, MiHee Lee, Zayar Soe, Alice W. Lee, Cam Van Doan, Dennis Deapen, Giske Ursin, Darcy Spicer, Peggy Reynolds, Anna H. Wu
    Cancer Causes & Control.2020; 31(2): 127.     CrossRef
  • Long-Term Outcomes of Immediate Autologous Breast Reconstruction for Breast Cancer Patients
    Akimitsu Yamada, Kazutaka Narui, Toshihiko Satake, Shoko Adachi, Mikiko Tanabe, Daisuke Shimizu, Takashi Ishikawa, Itaru Endo
    Journal of Surgical Research.2020; 251: 78.     CrossRef
  • Density of breast: An independent risk factor for developing breast cancer, a prospective study at two premium breast centers
    Chia Hwee Lo, Xin Ying Chai, Shirley Shy Wen Ting, Sze Chao Ang, Xinlin Chin, Lay Teng Tan, Peeroo Saania, Tuan Nur' Azmah Tuan Mat, Seniyah Mat Sikin, Anil Gandhi
    Cancer Medicine.2020; 9(9): 3244.     CrossRef
  • A Review of Breast Density Implications and Breast Cancer Screening
    Jingge Lian, Kangan Li
    Clinical Breast Cancer.2020; 20(4): 283.     CrossRef
  • Breast Cancer Incidence Trends by Estrogen Receptor Status Among Asian American Ethnic Groups, 1990–2014
    Alyssa W Tuan, Brittny C Davis Lynn, Pavel Chernyavskiy, Mandi Yu, Scarlett L Gomez, Gretchen L Gierach, Philip S Rosenberg
    JNCI Cancer Spectrum.2020;[Epub]     CrossRef
  • Supplemental breast cancer-screening ultrasonography in women with dense breasts: a systematic review and meta-analysis
    Wei-Hsin Yuan, Hui-Chen Hsu, Ying-Yuan Chen, Chia-Hung Wu
    British Journal of Cancer.2020; 123(4): 673.     CrossRef
  • Mammographic breast density, its changes, and breast cancer risk in premenopausal and postmenopausal women
    Eun Young Kim, Yoosoo Chang, Jiin Ahn, Ji‐Sup Yun, Yong Lai Park, Chan Heun Park, Hocheol Shin, Seungho Ryu
    Cancer.2020; 126(21): 4687.     CrossRef
  • Evaluation of automated volumetric breast density software in comparison with visual assessments in an Asian population
    Kartini Rahmat, Nazimah Ab Mumin, Marlina Tanty Ramli Hamid, Farhana Fadzli, Wei Lin Ng, Nadia Fareeda Muhammad Gowdh
    Medicine.2020; 99(39): e22405.     CrossRef
  • Prevalence of Women with Dense Breasts in Korea: Results from a Nationwide Cross-sectional Study
    Hye-Mi Jo, Eun Hye Lee, Kyungran Ko, Bong Joo Kang, Joo Hee Cha, Ann Yi, Hae Kyoung Jung, Jae Kwan Jun
    Cancer Research and Treatment.2019; 51(4): 1295.     CrossRef
  • Methodological Challenges and Updated Findings from a Meta-analysis of the Association between Mammographic Density and Breast Cancer
    Daniela Bond-Smith, Jennifer Stone
    Cancer Epidemiology, Biomarkers & Prevention.2019; 28(1): 22.     CrossRef
  • The role of breast tomosynthesis in a predominantly dense breast population at a tertiary breast centre: breast density assessment and diagnostic performance in comparison with MRI
    Daniel Förnvik, Masako Kataoka, Mami Iima, Akane Ohashi, Shotaro Kanao, Masakazu Toi, Kaori Togashi
    European Radiology.2018; 28(8): 3194.     CrossRef
  • Breast-density assessment with hand-held ultrasound: A novel biomarker to assess breast cancer risk and to tailor screening?
    Sergio J. Sanabria, Orcun Goksel, Katharina Martini, Serafino Forte, Thomas Frauenfelder, Rahel A. Kubik-Huch, Marga B. Rominger
    European Radiology.2018; 28(8): 3165.     CrossRef
  • The role of matricellular proteins and tissue stiffness in breast cancer: a systematic review
    Sirio Fiorino, Salomone Di Saverio, Paolo Leandri, Andrea Tura, Chiara Birtolo, Mauro Silingardi, Dario de Biase, Eli Avisar
    Future Oncology.2018; 14(16): 1601.     CrossRef
  • Molecular mechanisms of the preventable causes of cancer in the United States
    Erica A. Golemis, Paul Scheet, Tim N. Beck, Eward M. Scolnick, David J. Hunter, Ernest Hawk, Nancy Hopkins
    Genes & Development.2018; 32(13-14): 868.     CrossRef
  • Inactivated Sendai virus particle upregulates cancer cell expression of intercellular adhesion molecule‐1 and enhances natural killer cell sensitivity on cancer cells
    Simin Li, Tomoyuki Nishikawa, Yasufumi Kaneda
    Cancer Science.2017; 108(12): 2333.     CrossRef
The Effect of Breastfeeding Duration and Parity on the Risk of Epithelial Ovarian Cancer: A Systematic Review and Meta-analysis
Ho Kyung Sung, Seung Hyun Ma, Ji-Yeob Choi, Yunji Hwang, Choonghyun Ahn, Byoung-Gie Kim, Yong-Man Kim, Jae Weon Kim, Sokbom Kang, Jaehoon Kim, Tae Jin Kim, Keun-Young Yoo, Daehee Kang, Suekyung Park
J Prev Med Public Health. 2016;49(6):349-366.   Published online September 8, 2016
DOI: https://doi.org/10.3961/jpmph.16.066
  • 14,360 View
  • 294 Download
  • 49 Crossref
AbstractAbstract PDFSupplementary Material
Objectives
We conducted a systematic review and meta-analysis to summarize current evidence regarding the association of parity and duration of breastfeeding with the risk of epithelial ovarian cancer (EOC).
Methods
A systematic search of relevant studies published by December 31, 2015 was performed in PubMed and EMBASE. A random-effect model was used to obtain the summary relative risks (RRs) and 95% confidence intervals (CIs).
Results
Thirty-two studies had parity categories of 1, 2, and ≥3. The summary RRs for EOC were 0.72 (95% CI, 0.65 to 0.79), 0.57 (95% CI, 0.49 to 0.65), and 0.46 (95% CI, 0.41 to 0.52), respectively. Small to moderate heterogeneity was observed for one birth (p<0.01; Q=59.46; I2=47.9%). Fifteen studies had breastfeeding categories of <6 months, 6-12 months, and >13 months. The summary RRs were 0.79 (95% CI, 0.72 to 0.87), 0.72 (95% CI, 0.64 to 0.81), and 0.67 (95% CI, 0.56 to 0.79), respectively. Only small heterogeneity was observed for <6 months of breastfeeding (p=0.17; Q=18.79, I2=25.5%). Compared to nulliparous women with no history of breastfeeding, the joint effects of two births and <6 months of breastfeeding resulted in a 0.5-fold reduced risk for EOC.
Conclusions
The first birth and breastfeeding for <6 months were associated with significant reductions in EOC risk.
Summary

Citations

Citations to this article as recorded by  
  • Pelvic inflammatory disease and risk of epithelial ovarian cancer: a national population-based case-control study in Sweden
    Sarah Jonsson, Håkan Jonsson, Eva Lundin, Christel Häggström, Annika Idahl
    American Journal of Obstetrics and Gynecology.2024; 230(1): 75.e1.     CrossRef
  • Agricultural exposure and risk of ovarian cancer in the AGRIculture and CANcer (AGRICAN) cohort
    Marine Renier, Juliette Hippert, Louis-Bastien Weiswald, Séverine Tual, Matthieu Meryet-Figuiere, Nicolas Vigneron, Elisabeth Marcotullio, Isabelle Baldi, Pierre Lebailly
    Occupational and Environmental Medicine.2024; 81(2): 75.     CrossRef
  • Prenatal Counseling on the Maternal Health Benefits of Lactation: A Randomized Trial
    Eleanor B. Schwarz, Adrienne Hoyt-Austin, Margaret Fix, Laura R. Kair, Caidon Iwuagwu, Melissa J. Chen
    Breastfeeding Medicine.2024; 19(1): 52.     CrossRef
  • Awareness of the Maternal Health Benefits of Lactation Among U.S. Pregnant Individuals
    Caidon Iwuagwu, Melissa J. Chen, Adrienne E. Hoyt-Austin, Laura Kair, Margaret Fix, Eleanor Bimla Schwarz
    Women's Health Issues.2024;[Epub]     CrossRef
  • Ovulation induction drug and ovarian cancer: an updated systematic review and meta-analysis
    Liang Yu, Jiafan Sun, Qiqin Wang, Wennian Yu, Anqi Wang, Shu Zhu, Wei Xu, Xiuli Wang
    Journal of Ovarian Research.2023;[Epub]     CrossRef
  • La Salpingo-oforectomía o Salpingectomía como estrategia para prevenir el cáncer de ovario
    Scarlet Hochstatter Irarrázabal, Erwin Hochstatter Arduz
    Revista Medica.2023; 27(1): 26.     CrossRef
  • Stratifying the risk of ovarian cancer incidence by histologic subtypes in the Korean Epithelial Ovarian Cancer Study (Ko‐EVE)
    Soseul Sung, Youjin Hong, Byoung‐Gie Kim, Ji‐Yeob Choi, Jae Weon Kim, Sang‐Yoon Park, Jae‐Hoon Kim, Yong‐man Kim, Jong‐Min Lee, Tae Jin Kim, Sue K. Park
    Cancer Medicine.2023; 12(7): 8742.     CrossRef
  • Abortion and Female Cancer Risks among Women Aged 20 to 45 Years: A 10-Year Longitudinal Population-Based Cohort Study in Taiwan
    Cheng-Ting Shen, Shu-Yu Tai, Yu-Hsiang Tsao, Fang-Ming Chen, Hui-Min Hsieh
    International Journal of Environmental Research and Public Health.2023; 20(4): 3682.     CrossRef
  • Lifetime ovulatory years and risk of epithelial ovarian cancer: a multinational pooled analysis
    Zhuxuan Fu, Maria Mori Brooks, Sarah Irvin, Susan Jordan, Katja K H Aben, Hoda Anton-Culver, Elisa V Bandera, Matthias W Beckmann, Andrew Berchuck, Angela Brooks-Wilson, Jenny Chang-Claude, Linda S Cook, Daniel W Cramer, Kara L Cushing-Haugen, Jennifer A
    JNCI: Journal of the National Cancer Institute.2023; 115(5): 539.     CrossRef
  • Role of breastfeeding on maternal and childhood cancers: An umbrella review of meta-analyses
    Dazhi Fan, Qing Xia, Dongxin Lin, Yubo Ma, Jiaming Rao, Li Liu, Hai Tang, Tingting Xu, Pengsheng Li, Gengdong Chen, Zixing Zhou, Xiaoling Guo, Zhifang Zhang, Zhengping Liu
    Journal of Global Health.2023;[Epub]     CrossRef
  • What does a doctor need to know about breastfeeding and adolescent health and pregnancy?
    Leandro Meirelles Nunes, Rossiclei de Souza Pinheiro, Izailza Matos Dantas Lopes, Darci Vieira da Silva Bonetto, Alda Elizabeth Boehler Iglesias Azevedo
    Revista da Associação Médica Brasileira.2023;[Epub]     CrossRef
  • Deficiencies in the Intentions, Attitudes, and Knowledge of Future Healthcare Professionals Regarding Breastfeeding
    Marija Čatipović, Štefica Mikšić, Rajko Fureš, Zrinka Puharić, Dragica Pavlović
    Children.2023; 10(7): 1256.     CrossRef
  • Examining psychometric properties of the Iranian version of exclusive breastfeeding social support scale (EBFSS)
    Sepideh Mashayekh-Amiri, Mina Hosseinzadeh, Mohammad Asghari Jafarabadi, Sepideh Soltani, Mojgan Mirghafourvand
    BMC Psychology.2023;[Epub]     CrossRef
  • Are pregnancy and parity associated with telomere length? A systematic review
    Nourit Houminer-Klepar, Shiran Bord, Elissa Epel, Orna Baron-Epel
    BMC Pregnancy and Childbirth.2023;[Epub]     CrossRef
  • Global patterns and temporal trends in ovarian cancer morbidity, mortality, and burden from 1990 to 2019
    Afrooz Mazidimoradi, Zohre Momenimovahed, Yousef Khani, Armin Rezaei Shahrabi, Leila Allahqoli, Hamid Salehiniya
    Oncologie.2023; 25(6): 641.     CrossRef
  • Pregnancy, preeclampsia and maternal aging: From epidemiology to functional genomics
    Eliza C. Miller, Ashley Wilczek, Natalie A. Bello, Sarah Tom, Ronald Wapner, Yousin Suh
    Ageing Research Reviews.2022; 73: 101535.     CrossRef
  • Lifetime ovulations and epithelial ovarian cancer risk and survival: A systematic review and meta-analysis
    Zhuxuan Fu, Sarah Taylor, Francesmary Modugno
    Gynecologic Oncology.2022; 165(3): 650.     CrossRef
  • The Effects of Breastfeeding on Maternal Mental Health: A Systematic Review
    Megan Yuen, Olivia J. Hall, Grace A. Masters, Benjamin C. Nephew, Catherine Carr, Katherine Leung, Adrienne Griffen, Lynne McIntyre, Nancy Byatt, Tiffany A. Moore Simas
    Journal of Women's Health.2022; 31(6): 787.     CrossRef
  • Breastfeeding Among Pediatric Emergency Physicians
    Marissa Hendrickson, Cynthia S. Davey, Brian A. Harvey, Kari Schneider
    Pediatric Emergency Care.2022; 38(7): e1372.     CrossRef
  • A Follow-Up Study of Ovarian Cancer (OOPS): A Study Protocol
    Ting-Ting Gong, Fang-Hua Liu, Ya-Shu Liu, Shi Yan, He-Li Xu, Xin-Hui He, Yi-Fan Wei, Xue Qin, Song Gao, Yu-Hong Zhao, Qi-Jun Wu
    Frontiers in Nutrition.2022;[Epub]     CrossRef
  • Extraterrestrial Gynecology: Could Spaceflight Increase the Risk of Developing Cancer in Female Astronauts? An Updated Review
    Rosa Drago-Ferrante, Riccardo Di Fiore, Fathi Karouia, Yashwanth Subbannayya, Saswati Das, Begum Aydogan Mathyk, Shehbeel Arif, Ana Paula Guevara-Cerdán, Allen Seylani, Aman Singh Galsinh, Weronika Kukulska, Joseph Borg, Sherif Suleiman, David Marshall Po
    International Journal of Molecular Sciences.2022; 23(13): 7465.     CrossRef
  • Behaviour, Attitudes and Knowledge of Healthcare Workers on Breastfeeding
    Marija Čatipović, Zrinka Puharić, Drita Puharić, Paula Čatipović, Josip Grgurić
    Children.2022; 9(8): 1173.     CrossRef
  • Lactancia materna
    E. Raimond, N. Leloux, R. Gabriel
    EMC - Ginecología-Obstetricia.2022; 58(4): 1.     CrossRef
  • Human Milk Microbiota and Oligosaccharides: A Glimpse into Benefits, Diversity, and Correlations
    Carole Ayoub Moubareck
    Nutrients.2021; 13(4): 1123.     CrossRef
  • Couples talk about breastfeeding: Interviews with parents about decision-making, challenges, and the role of fathers and professional support
    Erin J Henshaw, Maria Mayer, Sarina Balraj, Elsie Parmar, Kristine Durkin, Rita Snell
    Health Psychology Open.2021; 8(2): 205510292110291.     CrossRef
  • Influence of lactation and nutrition on health of nursing woman
    S. V. Orlova, E. A. Nikitina, A. N. Vodolazkaya, L. Yu. Volkova, E. V. Prokopenko
    Medical alphabet.2021; (21): 75.     CrossRef
  • Supporting Exclusive Breastfeeding Among Factory Workers and Their Unemployed Neighbors: Peer Counseling in Bangladesh
    Rukhsana Haider, Virginia Thorley
    Journal of Human Lactation.2020; 36(3): 414.     CrossRef
  • The Ketogenic Diet Including Breast Milk for Treatment of Infants with Severe Childhood Epilepsy: Feasibility, Safety, and Effectiveness
    Anastasia Dressler, Chiara Häfele, Vito Giordano, Franz Benninger, Petra Trimmel-Schwahofer, Gudrun Gröppel, Sharon Samueli, Martha Feucht, Christoph Male, Andreas Repa
    Breastfeeding Medicine.2020; 15(2): 72.     CrossRef
  • Gender of offspring and risk of ovarian cancer: The HOPE study
    Zhuxuan Fu, Kirsten Moysich, Roberta B. Ness, Francesmary Modugno
    Cancer Epidemiology.2020; 64: 101646.     CrossRef
  • Ovarian cancer screening: Current status and future directions
    Zachary Nash, Usha Menon
    Best Practice & Research Clinical Obstetrics & Gynaecology.2020; 65: 32.     CrossRef
  • “I was determined to breastfeed, and I always found a solution”: successful experiences of exclusive breastfeeding among Chinese mothers in Ireland
    Qianling Zhou, Haoyue Chen, Katherine M. Younger, Tanya M. Cassidy, John M. Kearney
    International Breastfeeding Journal.2020;[Epub]     CrossRef
  • An Update on Screening and Prevention for Breast and Gynecological Cancers in Average and High Risk Individuals
    Anahid M Pahlawanian, Vanessa A Norris, Amelia M Jernigan, Brooke Morrell, Mignonne Morrell, Navya Nair, Amber M Karamanis, Erin M Dauchy, Michelle M Loch, Agustin A Garcia
    The American Journal of the Medical Sciences.2020; 360(5): 489.     CrossRef
  • Association of Social and Community Factors with U.S. Breastfeeding Outcomes
    Leslie Kummer, Naomi Duke, Laurel Davis, Iris Borowsky
    Breastfeeding Medicine.2020; 15(10): 646.     CrossRef
  • Breastfeeding Among Mothers Who Have Experienced Childhood Maltreatment: A Review
    Amara Channell Doig, Michelle Jasczynski, Jamie L. Fleishman, Elizabeth M. Aparicio
    Journal of Human Lactation.2020; 36(4): 710.     CrossRef
  • Offspring sex and risk of epithelial ovarian cancer: a multinational pooled analysis of 12 case–control studies
    Francesmary Modugno, Zhuxuan Fu, Susan J. Jordan, AOCS Group, Jenny Chang-Claude, Renée T. Fortner, Marc T. Goodman, Kirsten B. Moysich, Joellen M. Schildkraut, Andrew Berchuck, Elisa V. Bandera, Bo Qin, Rebecca Sutphen, John R. McLaughlin, Usha Menon, Su
    European Journal of Epidemiology.2020; 35(11): 1025.     CrossRef
  • Translational Theragnosis of Ovarian Cancer: where do we stand?
    Maria Grazia Perrone, Oreste Luisi, Anna De Grassi, Savina Ferorelli, Gennaro Cormio, Antonio Scilimati
    Current Medicinal Chemistry.2020; 27(34): 5675.     CrossRef
  • Breastfeeding factors and risk of epithelial ovarian cancer
    Francesmary Modugno, Sharon L. Goughnour, Danielle Wallack, Robert P. Edwards, Kunle Odunsi, Joseph L. Kelley, Kirsten Moysich, Roberta B. Ness, Maria Mori Brooks
    Gynecologic Oncology.2019; 153(1): 116.     CrossRef
  • Flexible piecewise linear model for investigating dose‐response relationship in meta‐analysis: Methodology, examples, and comparison
    Chang Xu, Lehana Thabane, Tongzu Liu, ASM Borhan, Xin Sun
    Journal of Evidence-Based Medicine.2019; 12(1): 63.     CrossRef
  • Critical questions in ovarian cancer research and treatment: Report of an American Association for Cancer Research Special Conference
    Robert C. Bast, Ursula A. Matulonis, Anil K. Sood, Ahmed A. Ahmed, Adaobi E. Amobi, Frances R. Balkwill, Monicka Wielgos‐Bonvallet, David D. L. Bowtell, James D. Brenton, Joan S. Brugge, Robert L. Coleman, Giulio F. Draetta, Kai Doberstein, Ronny I. Drapk
    Cancer.2019; 125(12): 1963.     CrossRef
  • Novel Approaches to Ovarian Cancer Screening
    Denise R. Nebgen, Karen H. Lu, Robert C. Bast
    Current Oncology Reports.2019;[Epub]     CrossRef
  • Age at last birth and risk of developing epithelial ovarian cancer: a meta-analysis
    Yanjun Wu, Wenjun Sun, Xueling Xin, Weijing Wang, Dongfeng Zhang
    Bioscience Reports.2019;[Epub]     CrossRef
  • The impact of historical breastfeeding practices on the incidence of cancer in France in 2015
    Kevin D. Shield, Laure Dossus, Agnès Fournier, Claire Marant Micallef, Sabina Rinaldi, Agnès Rogel, Isabelle Heard, Sophie Pilleron, Freddie Bray, Isabelle Soerjomataram
    Cancer Causes & Control.2018; 29(3): 325.     CrossRef
  • The role of pregnancy, perinatal factors and hormones in maternal cancer risk: a review of the evidence
    R. Troisi, T. Bjørge, M. Gissler, T. Grotmol, C. M. Kitahara, S. M. Myrtveit Sæther, A. G. Ording, C. Sköld, H. T. Sørensen, B. Trabert, I. Glimelius
    Journal of Internal Medicine.2018; 283(5): 430.     CrossRef
  • Ovarian Cancer Prevention and Screening
    Usha Menon, Chloe Karpinskyj, Aleksandra Gentry-Maharaj
    Obstetrics & Gynecology.2018; 131(5): 909.     CrossRef
  • Breastfeeding experience, challenges and service demands among Chinese mothers: A qualitative study in two cities
    Yan Zhang, Yi Jin, Carel Vereijken, Bernd Stahl, Hong Jiang
    Appetite.2018; 128: 263.     CrossRef
  • Postpartum Cardiomyopathy and Considerations for Breastfeeding
    Laura Kearney, Paul Wright, Sadeer Fhadil, Martin Thomas
    Cardiac Failure Review.2018; 4(2): 112.     CrossRef
  • Breastfeeding and the Benefits of Lactation for Women's Health
    Luiz Antonio Del Ciampo, Ieda Regina Lopes Del Ciampo
    Revista Brasileira de Ginecologia e Obstetrícia / RBGO Gynecology and Obstetrics.2018; 40(06): 354.     CrossRef
  • Ovarian Cancer Prevention in High-risk Women
    SARAH M. TEMKIN, JENNIFER BERGSTROM, GOLI SAMIMI, LORI MINASIAN
    Clinical Obstetrics & Gynecology.2017; 60(4): 738.     CrossRef
  • Risk Reduction of Breast Cancer by Childbirth, Breastfeeding, and Their Interaction in Korean Women: Heterogeneous Effects Across Menopausal Status, Hormone Receptor Status, and Pathological Subtypes
    Seok Hun Jeong, Yoon Suk An, Ji-Yeob Choi, Boyoung Park, Daehee Kang, Min Hyuk Lee, Wonshik Han, Dong Young Noh, Keun-Young Yoo, Sue K. Park
    Journal of Preventive Medicine and Public Health.2017; 50(6): 401.     CrossRef

JPMPH : Journal of Preventive Medicine and Public Health